3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
10
Obesity
3
Neoplasms
3
Sarcopenia
2
Prostatic Neoplasms
2
Polycystic Ovary Syndrome
2
Colorectal Neoplasms
2
Wound Infection
1
Weight Loss
1
Urinary Bladder Neoplasms
1
Surgical Wound Infection
1
Stomach Neoplasms
1
Smoldering Multiple Myeloma
1
Skin Neoplasms
1
Psoriasis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Postoperative Complications
1
Phagocyte Bactericidal Dysfunction
1
Pain
1
Overweight
1
Osteoarthritis
1
Olfaction Disorders
1
Non-alcoholic Fatty Liver Disease
1
Neuroma, Acoustic
1
Neoplasm, Residual
1
Nasopharyngeal Carcinoma
1
Multiple Myeloma
1
Monoclonal Gammopathy of Undetermined Significance
1
Mandibular Neoplasms
1
Interventions
Etanercept
12
Adalimumab
12
Infliximab
7
golimumab
4
Tumor Necrosis Factor Inhibitors
4
Certolizumab Pegol
4
Abatacept
4
tofacitinib
2
tocilizumab
2
Rituximab
2
Antirheumatic Agents
2
Vitamin D
1
Vaccines
1
Syringes
1
Surveys and Questionnaires
1
Standard of Care
1
Sodium Chloride
1
Saline Solution
1
Radioimmunodetection
1
Prednisone
1
Practice Guidelines as Topic
1
Phlebotomy
1
Observation
1
Nivolumab
1
Methotrexate
1
Methods
1
Lysine Acetyltransferase 5
1
Licensure
1
Leflunomide
1
Interviews as Topic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Arthritis, Rheumatoid
×
Docosahexaenoic Acids
×
Clear all
NCT01351805
2025-12-03
VITAL
Brigham and Women's Hospital
Phase NA
Completed
25,871 enrolled
15 charts